Dallas, TX, November 28, 2016 --(PR.com
)-- The market for Topical Drug Delivery is expected to reach USD 205.1 billion by 2024 from USD 101.7 billion in 2016, growing at 9.2% during the forecast years to 2024.
The global topical drug delivery market is segmented on the basis of product type, distribution channel, end user and geography.
Request for sample pages: http://databridgemarketresearch.com/reports/global-topical-drug-delivery-market-trends-forecast-2024/
On the basis of product type the market is segmented into transdermal drug delivery devices and topical drug delivery formulations. Topical drug delivery formulations are further segmented into solid, semi-solid and liquid. The semi solid segment is further classified into ointments, creams, lotions, gels and pastes. The solid drugs segment is further segmented into powders and suppositors. The liquid drugs segment is further classified into solutions and suspensions. The transdermal drug delivery devices market segment is further segmented into patches and gels.
Based on end users the market is segmented into hospitals, home healthcare, clinics, diagnostic centers, and others.
On the basis of distribution channel the market is segmented into Direct Tenders and Retail.
The major geographies covered in the reports scope are North America, Europe, Asia-Pacific, South America and rest of the world. The report of this market is further segmented into the countries like U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, and South Africa.
Read more: http://databridgemarketresearch.com/reports/global-topical-drug-delivery-market-trends-forecast-2024/
The major players operating in this market are MedPharm, Janssen Pharmaceuticals, Inc. (A J&J Company), Crescita Therapeutics, West Pharmaceutical Services, Galderma S.A., Biofarmitalia s.r.l, Pharmatek Laboratories, Inc., Stiefel Laboratories, Inc., Tapemark, Acrux Limited, Nitto Denko Corporation, Valeant Pharmaceuticals International, Inc., Skinvisible Pharmaceuticals, Inc., Mylan Pharmaceuticals Inc., Hisamitsu Pharmaceutical Co., Inc., Pocono Coated Products LLC, TheraSolve NV., Samyang Biopharmaceuticals Corporation, Lohmann Therapie-Systeme AG, Prosollus Pharmaceuticals, Easton Pharmaceuticals Inc., Novosis AG, Antares Pharma, Inc., Endo Pharmaceuticals Inc., Transdermal Technologies, Inc., Sheffield Pharmaceuticals, Inc., Solvay, and 3M Drug Delivery Systems among other vernacular players.
About Data Bridge Market Research:
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.